Discovery Life Sciences Acquires Gentest Business from Corning Incorporated
April 5, 2022
Discovery Life Sciences has acquired the Gentest business unit from Corning Incorporated to expand its in vitro ADME and toxicology reagent and services offering. The deal complements Discovery’s recent acquisition of In Vitro ADMET Laboratories (IVAL) and strengthens its hepatocyte, microsome and ADME-related product and contracted research capabilities for pharmaceutical and life sciences customers.
- Buyers
- Discovery Life Sciences
- Targets
- Gentest (business unit of Corning Incorporated)
- Sellers
- Corning Incorporated
- Industry
- Biotechnology
- Location
- Massachusetts, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Discovery Life Sciences Acquires In Vitro ADMET Laboratories (IVAL)
December 2, 2021
Healthcare Services
Discovery Life Sciences has acquired Maryland-based In Vitro ADMET Laboratories (IVAL) to add the world’s largest hepatocyte inventory and leading in vitro ADMET expertise. IVAL founder Albert P. Li, Ph.D. will join Discovery as Chief Scientific Officer of Pharmacology and Toxicology as Discovery expands its biospecimen and biomarker service capabilities to better support drug metabolism, toxicology, and pharmacology testing for pharma customers.
-
Eurofins Discovery Acquires DiscoveryBioMed
July 5, 2022
Biotechnology
Eurofins Discovery has acquired DiscoveryBioMed, a Birmingham, Alabama–based contract research organization specializing in human primary- and immortalized-cell based bioassays. The acquisition strengthens Eurofins Discovery’s translational biology and human cell assay capabilities to expand its drug discovery services portfolio.
-
Eurofins Acquires Genetic Testing Service JSC (Gentis) in Vietnam
February 9, 2022
Healthcare Services
Eurofins Scientific, via its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a leading provider of specialised genetic and clinical testing in Vietnam. The acquisition expands Eurofins' clinical diagnostics footprint in Southeast Asia and adds Gentis' genetic testing capabilities and customer relationships with hospitals and consumers.
-
Discovery Life Sciences Acquires QualTek Molecular Laboratories
May 5, 2019
Healthcare Services
Discovery Life Sciences (based in Huntsville, Alabama) has acquired QualTek Molecular Laboratories, a provider of CAP/CLIA-accredited and GLP-capable immunohistochemistry (IHC) laboratories in California and Pennsylvania. The acquisition expands Discovery's histopathology and IHC assay development capabilities and integrates QualTek's services with Discovery's biospecimen, sequencing, flow cytometry and multiomic annotation offerings to accelerate biomarker validation and drug/diagnostic development.
-
Eurofins (via Eurofins Clinical Testing Lux) Acquires Genetic Testing Service JSC (Gentis) in Vietnam
February 9, 2022
Healthcare Services
Eurofins Scientific, through its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a market leader in specialised genetic testing in Vietnam. The deal expands Eurofins' footprint in Southeast Asia and strengthens its clinical genetics and advanced molecular diagnostics capabilities in the region.
-
BioIVT Acquires XenoTech from Sekisui Chemical
September 12, 2022
Biotechnology
BioIVT has acquired XenoTech, a Kansas City–based provider of ADME‑Tox in vitro models and contract research services, from Sekisui Chemical. The acquisition expands BioIVT's hepatic product portfolio and ADME/DMPK capabilities to better support biopharma customers' preclinical testing needs. Financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.